Literature DB >> 21437822

Asherman's syndrome.

Charles M March1.   

Abstract

Asherman's syndrome is being diagnosed with increasing frequency. Although it usually occurs following curettage of the pregnant or recently pregnant uterus, any uterine surgery can lead to intrauterine adhesions (IUA). Most women with IUA have amenorrhea or hypomenorrhea, but up to a fourth have painless menses of normal flow and duration. Those who have amenorrhea may also have cyclic pelvic pain caused by outflow obstruction. The accompanying retrograde menstruation may lead to endometriosis. In addition to abnormal menses, infertility and recurrent spontaneous abortion are common complaints. Hysteroscopy is the standard method to both diagnose and treat this condition. Various techniques for adhesiolysis and for prevention of scar reformation have been advocated. The most efficacious appears to be the use of miniature scissors for adhesiolysis and the placement of a balloon stent inside the uterus immediately after surgery. Postoperative estrogen therapy is prescribed to stimulate endometrial regrowth. Follow-up studies to assure resolution of the scarring are mandatory before the patient attempts to conceive as is careful monitoring of pregnancies for cervical incompetence, placenta accreta, and intrauterine growth retardation. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21437822     DOI: 10.1055/s-0031-1272470

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  25 in total

1.  A tissue-engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization, and menstruation.

Authors:  Stacey C Schutte; Robert N Taylor
Journal:  Fertil Steril       Date:  2012-02-10       Impact factor: 7.329

2.  Creation of a rabbit model for intrauterine adhesions using electrothermal injury.

Authors:  Xin-Xin Xu; Lian-Bao Cao; Zhe Wang; Zhen Xu; Bing-Qian Zhang; She-Ling Wu; Sha-Sha Qi; Lei Yan; Zi-Jiang Chen
Journal:  J Zhejiang Univ Sci B       Date:  2018-05       Impact factor: 3.066

3.  Metformin Promotes Regeneration of the Injured Endometrium Via Inhibition of Endoplasmic Reticulum Stress-Induced Apoptosis.

Authors:  Xin-Xin Xu; Si-Si Zhang; Hui-Long Lin; Qi Lin; Lai-En Shen; Emmanuel Ansong; Xue-Qing Wu
Journal:  Reprod Sci       Date:  2018-11-22       Impact factor: 3.060

4.  Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience.

Authors:  Lusine Aghajanova; Viji Sundaram; Chia-Ning Kao; Joseph M Letourneau; Evelyna Manvelyan; Marcelle I Cedars; Heather G Huddleston
Journal:  J Assist Reprod Genet       Date:  2021-10-06       Impact factor: 3.412

5.  Outcome of Index Pregnancy in Women with Recurrent Pregnancy Loss (RPL).

Authors:  Paapa Dasari; G Suganya
Journal:  J Obstet Gynaecol India       Date:  2022-01-16

6.  Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.

Authors:  Stacy Young; Charles E Miller
Journal:  F S Rep       Date:  2022-03-10

7.  Placenta accreta: adherent placenta due to Asherman syndrome.

Authors:  Line Engelbrechtsen; Jens Langhoff-Roos; Jens Joergen Kjer; Olav Istre
Journal:  Clin Case Rep       Date:  2015-01-22

8.  Study on the correlation among dysbacteriosis, imbalance of cytokine and the formation of intrauterine adhesion.

Authors:  Xingping Zhao; Qun Zhao; Xiuting Zhu; Huan Huang; Xing Wan; Rui Guo; Yanqiu Zhao; Dan Chen; Dabao Xu
Journal:  Ann Transl Med       Date:  2020-02

Review 9.  Hysterosalpingography finding in intra uterine adhesion (asherman' s syndrome): a pictorial essay.

Authors:  Firoozeh Ahmadi; Shiva Siahbazi; Farnaz Akhbari; Bita Eslami; Ahmad Vosough
Journal:  Int J Fertil Steril       Date:  2013-09-18

Review 10.  Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases.

Authors:  Zhiqi Liao; Chang Liu; Lan Wang; Cong Sui; Hanwang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.